{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:10:50Z","timestamp":1773411050662,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Provincial Department of Science and Technology","award":["WSR2023006"],"award-info":[{"award-number":["WSR2023006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04597-x","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:53:01Z","timestamp":1770555181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a prognostic risk score model for malignant mesothelioma"],"prefix":"10.1007","volume":"17","author":[{"given":"Qingzheng","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longkun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuezhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"issue":"5","key":"4597_CR1","first-page":"402","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone M, Adusumilli PS, Alexander HR, et al. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69(5):402\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"4597_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jtho.2017.04.002","volume":"12","author":"B Liu","year":"2017","unstructured":"Liu B, Van Gerwen M, Bonassi S, et al. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12(7):1031\u201345.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"4597_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020;10(8):1103\u201320.","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"4597_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.21037\/tlcr.2020.02.03","volume":"9","author":"M Carbone","year":"2020","unstructured":"Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):S47\u201359.","journal-title":"Transl Lung Cancer Res"},{"issue":"6","key":"4597_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Pang WS, et al. Global Incidence, risk Factors, and Temporal trends of mesothelioma: A Population-Based study. J Thorac Oncol. 2023;18(6):792\u2013802.","journal-title":"J Thorac Oncol"},{"issue":"2\u20133","key":"4597_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","volume":"9","author":"H Yang","year":"2008","unstructured":"Yang H, Testa JR, Carbone M. Mesothelioma Epidemiology, Carcinogenesis, and pathogenesis. Curr Treat Options Oncol. 2008;9(2\u20133):147\u201357.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"4597_CR7","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4597_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","volume":"17","author":"JL Sauter","year":"2022","unstructured":"Sauter JL, Dacic S, Galateau-Salle F, et al. The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification. J Thorac Oncol. 2022;17(5):608\u201322.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"4597_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.6004\/jnccn.2023.0045","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger DS, Wood DE, Stevenson J, et al. Mesothelioma: Peritoneal, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(9):961\u201379.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"4597_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","volume":"41","author":"V Panou","year":"2015","unstructured":"Panou V, Vyberg M, Weinreich UM, et al. The established and future biomarkers of malignant pleural mesothelioma. Cancer Treat Rev. 2015;41(6):486\u201395.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4597_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","volume":"16","author":"D Curran","year":"1998","unstructured":"Curran D, Sahmoud T, Therasse P, et al. Prognostic factors in patients with pleural mesothelioma: the European organization for research and treatment of cancer experience. JCO. 1998;16(1):145\u201352.","journal-title":"JCO"},{"issue":"1","key":"4597_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/bjc.2012.245","volume":"107","author":"S Van Der Bij","year":"2012","unstructured":"Van Der Bij S, Koffijberg H, Burgers JA, et al. Prognosis and prognostic factors of patients with mesothelioma: a population-based study. Br J Cancer. 2012;107(1):161\u20134.","journal-title":"Br J Cancer"},{"issue":"4","key":"4597_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41588-023-01321-1","volume":"55","author":"L Mangiante","year":"2023","unstructured":"Mangiante L, Alcala N, Sexton-Oates A, et al. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 2023;55(4):607\u201318.","journal-title":"Nat Genet"},{"issue":"1","key":"4597_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","volume":"15","author":"AG Nicholson","year":"2020","unstructured":"Nicholson AG, Sauter JL, Nowak AK, et al. EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol. 2020;15(1):29\u201349.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4597_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-020-02980-9","volume":"478","author":"L Fernandez-Cuesta","year":"2021","unstructured":"Fernandez-Cuesta L, Mangiante L, Alcala N, et al. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Virchows Arch. 2021;478(1):73\u201380.","journal-title":"Virchows Arch"},{"key":"4597_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.lungcan.2017.09.015","volume":"113","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma. Lung Cancer. 2017;113:128\u201333.","journal-title":"Lung Cancer"},{"issue":"36","key":"4597_CR17","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1200\/JCO.2007.12.5294","volume":"25","author":"A Bottomley","year":"2007","unstructured":"Bottomley A, Coens C, Efficace F, et al. Symptoms and Patient-Reported Well-Being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. JCO. 2007;25(36):5770\u20136.","journal-title":"JCO"},{"issue":"3","key":"4597_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","volume":"7","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Mauri FA, Ramakrishnan R, et al. Inflammation-Based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2012;7(3):587\u201394.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"4597_CR19","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jtho.2021.06.014","volume":"16","author":"BY Yeap","year":"2021","unstructured":"Yeap BY, De Rienzo A, Gill RR, et al. Mesothelioma risk score: A new prognostic Pretreatment, Clinical-Molecular algorithm for malignant pleural mesothelioma. J Thorac Oncol. 2021;16(11):1925\u201335.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"4597_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/his.15065","volume":"84","author":"JJ Schulte","year":"2024","unstructured":"Schulte JJ, Husain AN. Updates on grading mesothelioma. Histopathology. 2024;84(1):153\u201362.","journal-title":"Histopathology"},{"issue":"12","key":"4597_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jtho.2023.08.005","volume":"18","author":"AS Wolf","year":"2023","unstructured":"Wolf AS, Rosenthal A, Giroux DJ, et al. The international association for the study of lung cancer pleural mesothelioma staging project: updated modeling of prognostic factors in pleural mesothelioma. J Thorac Oncol. 2023;18(12):1689\u2013702.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"4597_CR22","first-page":"100155","volume":"2","author":"RA Belderbos","year":"2021","unstructured":"Belderbos RA, Maat APWM, Baart SJ, et al. Ki67 (MIB-1) as a prognostic marker for clinical decision making before extended pleurectomy decortication in malignant pleural mesothelioma. JTO Clin Res Rep. 2021;2(4):100155.","journal-title":"JTO Clin Res Rep"},{"issue":"9","key":"4597_CR23","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.3390\/ijms26094299","volume":"26","author":"T Kato","year":"2025","unstructured":"Kato T, Tanaka I, Huang H, et al. Molecular mechanisms of tumor progression and novel therapeutic and diagnostic strategies in mesothelioma. IJMS. 2025;26(9):4299.","journal-title":"IJMS"},{"issue":"7","key":"4597_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"1","key":"4597_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-025-00640-3","volume":"11","author":"DA Fennell","year":"2025","unstructured":"Fennell DA, Sekido Y, Baas P, et al. Pleural mesothelioma. Nat Rev Dis Primers. 2025;11(1):56.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"4597_CR26","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/cncr.25640","volume":"117","author":"TD Yan","year":"2011","unstructured":"Yan TD, Deraco M, Elias D, et al. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer. 2011;117(9):1855\u201363.","journal-title":"Cancer"},{"issue":"1","key":"4597_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-018-0872-3","volume":"17","author":"Y-F Yang","year":"2018","unstructured":"Yang Y-F, Zhang M-F, Tian Q-H, et al. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K\/AKT pathway in hepatocellular carcinoma. Mol Cancer. 2018;17(1):117.","journal-title":"Mol Cancer"},{"issue":"7","key":"4597_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2020.03.006","volume":"6","author":"J He","year":"2020","unstructured":"He J, Green AR, Li Y, et al. SPAG5: an emerging oncogene. Trends Cancer. 2020;6(7):543\u20137.","journal-title":"Trends Cancer"},{"issue":"7","key":"4597_CR29","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1470-2045(16)00174-1","volume":"17","author":"TMA Abdel-Fatah","year":"2016","unstructured":"Abdel-Fatah TMA, Agarwal D, Liu D-X, et al. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. Lancet Oncol. 2016;17(7):1004\u201318.","journal-title":"Lancet Oncol"},{"issue":"6","key":"4597_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/2211-5463.12639","volume":"9","author":"X Cheng","year":"2019","unstructured":"Cheng X, Wang X, Wu Z, et al. CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro. FEBS Open Bio. 2019;9(6):1097\u2013108.","journal-title":"FEBS Open Bio"},{"key":"4597_CR31","doi-asserted-by":"publisher","first-page":"682594","DOI":"10.3389\/fmolb.2021.682594","volume":"8","author":"Z Wang","year":"2021","unstructured":"Wang Z, Jia L, Sun Y, et al. CORO1C is associated with poor prognosis and promotes metastasis through PI3K\/AKT pathway in colorectal cancer. Front Mol Biosci. 2021;8:682594.","journal-title":"Front Mol Biosci"},{"issue":"11","key":"4597_CR32","doi-asserted-by":"publisher","first-page":"105351","DOI":"10.1016\/j.jbc.2023.105351","volume":"299","author":"T Qiu","year":"2023","unstructured":"Qiu T, Hou L, Zhao L, et al. SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1. J Biol Chem. 2023;299(11):105351.","journal-title":"J Biol Chem"},{"issue":"14","key":"4597_CR33","doi-asserted-by":"publisher","first-page":"1903700","DOI":"10.1002\/advs.201903700","volume":"7","author":"L Zhao","year":"2020","unstructured":"Zhao L, Qiu T, Jiang D, et al. SGCE promotes breast cancer stem cells by stabilizing EGFR. Adv Sci (Weinh). 2020;7(14):1903700.","journal-title":"Adv Sci (Weinh)"},{"key":"4597_CR34","doi-asserted-by":"publisher","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu K, Xu Y, et al. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 2025;16:1678907.","journal-title":"Front Immunol"},{"key":"4597_CR35","doi-asserted-by":"crossref","unstructured":"Wang P, Xu S, Guo Q et al. Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques. Ren M, editor. Stem Cells International. 2025;2025(1):1325262.","DOI":"10.1155\/sci\/1325262"},{"issue":"3","key":"4597_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/biomedicines11030825","volume":"11","author":"W Zhu","year":"2023","unstructured":"Zhu W, Chen Q, Li Y, et al. HIF-1\u03b1-Overexpressing mesenchymal stem cells attenuate colitis by regulating M1-like macrophages polarization toward M2-like macrophages. Biomedicines. 2023;11(3):825.","journal-title":"Biomedicines"},{"issue":"7","key":"4597_CR37","doi-asserted-by":"publisher","first-page":"e012069","DOI":"10.1136\/jitc-2025-012069","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(7):e012069.","journal-title":"J Immunother Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04597-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:06:29Z","timestamp":1773396389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04597-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4597"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04597-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee for Biomedical Research Involving Human Subjects of Shandong Provincial Hospital, with a waiver of informed consent due to the retrospective design and use of de-identified data. The requirement for informed consent was waived by the Ethics Committee for Biomedical Research Involving Human Subjects of Shandong Provincial Hospital because of the retrospective study design and use of archived specimens and de-identified clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"415"}}